Company Introduction
Innovative nanomedicine specialist
DR.Cure is a startup founded in 2020 by two co-founders based on the technology developed
while carrying out the national proprietary technology project funded by the ministy of science and ICT.
Currently, we are striving to become a global leader in radiotherapeutic nanomedicine.
while carrying out the national proprietary technology project funded by the ministy of science and ICT.
Currently, we are striving to become a global leader in radiotherapeutic nanomedicine.
Nanoparticles to overcome
hypoxic tumor environment
hypoxic tumor environment
DR.Cure’s proprietary manganese oxide nanoparticle maximize
the treatment efficiency of radiotherapy for intractable solid
cancers such as colorectal cancer through reoxygenating
the hypoxic(low oxygen level) tumor microenvironment.
the treatment efficiency of radiotherapy for intractable solid
cancers such as colorectal cancer through reoxygenating
the hypoxic(low oxygen level) tumor microenvironment.
